CELEX: 62020TA0098
Language: en
Date: 2021-02-10 00:00:00
Title: Case T-98/20: Judgment of the General Court of 10 February 2021 — Biochange Group v EUIPO — mysuperbrand (medical beauty research) (EU trade mark — Invalidity proceedings — EU word mark medical beauty research — Absolute grounds for refusal — Descriptiveness — Article 7(1)(c) of Regulation (EC) No 40/94 (now Article 7(1)(c) of Regulation (EU) 2017/1001) — Lack of distinctive character — Article 7(1)(b) of Regulation No 40/94 (now Article 7(1)(b) of Regulation 2017/1001) — Consideration of the facts — Article 95(1) of Regulation 2017/1001)

29.3.2021   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 110/28
            
         
      Judgment of the General Court of 10 February 2021 — Biochange Group v EUIPO — mysuperbrand (medical beauty research)
      (Case T-98/20) (1)
      
      (EU trade mark - Invalidity proceedings - EU word mark medical beauty research - Absolute grounds for refusal - Descriptiveness - Article 7(1)(c) of Regulation (EC) No 40/94 (now Article 7(1)(c) of Regulation (EU) 2017/1001) - Lack of distinctive character - Article 7(1)(b) of Regulation No 40/94 (now Article 7(1)(b) of Regulation 2017/1001) - Consideration of the facts - Article 95(1) of Regulation 2017/1001)
      (2021/C 110/31)
      Language of the case: German
      
         Parties
      
      
         Applicant: Biochange Group GmbH (Bad Schlema, Germany) (represented by: C. König, lawyer)
      
         Defendant: European Union Intellectual Property Office (represented by: D. Walicka, acting as Agent)
      
         Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: mysuperbrand GmbH, formerly Laubender GmbH (Vienna, Austria) (represented by: M. Woller, lawyer)
      
         Re:
      
      Action brought against the decision of the Second Board of Appeal of EUIPO of 8 November 2019 (Case R 114/2019-2) relating to invalidity proceedings between Laubender and Biochange Group.
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  Annuls the decision of the Second Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 8 November 2019 (Case R 114/2019-2) as regards ‘baby food’ in Class 5 of the Nice Agreement Concerning the International Classification of Goods and Services for the Purposes of the Registration of Marks of 15 June 1957, as revised and amended;
               
            
                  2.
               
               
                  Dismisses the action as to the remainder;
               
            
                  3.
               
               
                  Orders Biochange Group GmbH, EUIPO and mysuperbrand GmbH each to bear their own costs.
               
            
         (1)  OJ C 114, 6.4.2020.